Sunitinib versus cabozantinib, crizotinib or savolitinib in metastatic papillary renal cell carcinoma (pRCC): Results from the randomized phase II SWOG 1500 study. MET signaling is a key molecular driver in papillary renal cell...
1) In an updated analysis of the phase 2 DESTINY-Breast01 study, women with HER2-positive metastatic breast cancer ADC trastuzumab deruxtecan (Enhertu) continued to demonstrate favorable data, including a median progression-free...
It’s no question that advancements in the treatment of age-related macular degeneration were...
1) According to the FOURIER trial, patients treated with PCSK9 inhibitors had a reduced risk for venous thromboembolism (VTE), especially if they had elevated what? a) LDL b) Lipoprotein(a) c) Both d) None of the above The...
Test your knowledge on results on PsA released at ACR Convergence 2020 – take our quiz and...